Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Herrmann

Showing results (71-80 of 269) with videos related to

Pageof 27
Sort By:
Pharmacology & Therapeutics|March 20, 2013
Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicityNicola Ferri, Peter Siegl, Alberto Corsini, et al.
Cardio-Oncology (London, England)|April 14, 2026
The pulmonary artery hypertension and cancer: PULAHYCA PILOT study. Initial prostanoid therapy in cancer patients with pulmonary hypertension: results from an observational studyVanesa Gregorietti, Teresa López-Fernández, Joerg Herrmann, et al.
Future Oncology (London, England)|July 23, 2015
Cardio-oncology: an ongoing evolutionBradley J Petek, Chris Greenman, Joerg Herrmann, et al.
European Heart Journal|December 2, 2004
Myocardial bridging is associated with alteration in coronary vasoreactivityJoerg Herrmann, Stuart T Higano, Ryan J Lenon, et al.
JACC. Cardiovascular Interventions|April 20, 2019
Utility and Challenges of an Early Invasive Strategy in Patients Resuscitated From Out-of-Hospital Cardiac ArrestJacob C Jentzer, Joerg Herrmann, Abhiram Prasad, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2018
Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysisSandhya Manohar, Panagiotis Kompotiatis, Charat Thongprayoon, et al.
Frontiers in Immunology|February 19, 2021
Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor TherapyWhitney Barham, Ruifeng Guo, Sean S Park, et al.
Current Treatment Options in Cardiovascular Medicine|April 9, 2018
Arterial Thrombosis in Patients with CancerMirela Tuzovic, Joerg Herrmann, Cezar Iliescu, et al.
European Heart Journal|March 15, 2005
Myocardial bridgingJorge R Alegria, Joerg Herrmann, David R Holmes, et al.
Atherosclerosis|March 19, 2011
Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effectDallit Mannheim, Joerg Herrmann, Piero O Bonetti, et al.
Pageof 27

Showing results (71-80 of 269) with videos related to

Sort By:
Pageof 27
Pharmacology & Therapeutics|March 20, 2013
Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicityNicola Ferri, Peter Siegl, Alberto Corsini, et al.
Cardio-Oncology (London, England)|April 14, 2026
The pulmonary artery hypertension and cancer: PULAHYCA PILOT study. Initial prostanoid therapy in cancer patients with pulmonary hypertension: results from an observational studyVanesa Gregorietti, Teresa López-Fernández, Joerg Herrmann, et al.
Future Oncology (London, England)|July 23, 2015
Cardio-oncology: an ongoing evolutionBradley J Petek, Chris Greenman, Joerg Herrmann, et al.
European Heart Journal|December 2, 2004
Myocardial bridging is associated with alteration in coronary vasoreactivityJoerg Herrmann, Stuart T Higano, Ryan J Lenon, et al.
JACC. Cardiovascular Interventions|April 20, 2019
Utility and Challenges of an Early Invasive Strategy in Patients Resuscitated From Out-of-Hospital Cardiac ArrestJacob C Jentzer, Joerg Herrmann, Abhiram Prasad, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2018
Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysisSandhya Manohar, Panagiotis Kompotiatis, Charat Thongprayoon, et al.
Frontiers in Immunology|February 19, 2021
Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor TherapyWhitney Barham, Ruifeng Guo, Sean S Park, et al.
Current Treatment Options in Cardiovascular Medicine|April 9, 2018
Arterial Thrombosis in Patients with CancerMirela Tuzovic, Joerg Herrmann, Cezar Iliescu, et al.
European Heart Journal|March 15, 2005
Myocardial bridgingJorge R Alegria, Joerg Herrmann, David R Holmes, et al.
Atherosclerosis|March 19, 2011
Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effectDallit Mannheim, Joerg Herrmann, Piero O Bonetti, et al.
Pageof 27